Shares of Moderna Inc.
MRNA,
+5.81%

gained 6.3% in trading on Tuesday after the company said its COVID-19 vaccine has been authorized for adults in India. Moderna’s shot has already been authorized in more than 50 countries, including the U.S. Moderna’s stock is up 118.5% this year, while the broader S&P 500
SPX,
+0.11%

has gained 14.2%.

Read More